FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W930497132> ?p ?o ?g. }

• W930497132 endingPage "46" @default.
• W930497132 startingPage "40" @default.
• W930497132 abstract "Evaluation of the efficacy of antiepileptic drugs (AEDs) used in the treatment of Dravet syndrome (DS) with different genotypes.Patients with DS were recruited from different tertiary hospitals. Using a direct sequencing method and Multiplex Ligation-Dependent Probe Amplification (MLPA), genetic abnormalities were assessed within the exons and flanking introns of SCN1A gene, which encodes the α1 subunit of neuronal sodium channels. Patients were divided into SCN1A-positive and SCN1A-negative groups according to the results of genetic tests. Medical records, including detailed treatment information, were surveyed to compare the effect of different AEDs on clonic or tonic-clonic seizures (GTCS). Efficacy variable was responder rate with regard to seizure reduction.One hundred and sixty of 276 (57.97%) patients had mutation in SCN1A gene (only 128 of them had provided detailed medical records). Among the 116 patients without SCN1A mutations, 87 had provided detailed medical records. Both older AEDs (valproate, phenobarbital, bromide, carbamazepine, clonazepam, and clobazam) and newer AEDs such as zonisamide were used in these patients. Valproate was the most frequently used AED (86.72% in the SCN1A-positive group, 78.16% in the SCN1A-negative group), with 52.25% and 41.18% responder rates in SCN1A-positive and SCN1A-negative patients, respectively (P=0.15). Bromide was used in 40.63% of the SCN1A-positive patients and 20.69% of the SCN1A-negative patients, and its responder rates were 71.15% and 94.44% in SCN1A-positive and SCN1A-negative patients, respectively (P=0.05). Efficacy rates of clonazepam, clobazam, phenobarbital, and zonisamide ranged from 30% to 50%, and these rates were not correlated with different genotypes (P>0.05). Carbamazepine had either no effect or aggravated seizures in all SCN1A-positive patients.Bromide is most effective and is a well-tolerated drug among DS patients, especially among SCN1A-negative patients. Carbamazepine should be avoided in patients with SCN1A mutations." @default.
• W930497132 created "2016-06-24" @default.
• W930497132 creator A5013245506 @default.
• W930497132 creator A5045525134 @default.
• W930497132 creator A5046996814 @default.
• W930497132 creator A5054303004 @default.
• W930497132 creator A5054952702 @default.
• W930497132 creator A5073459365 @default.
• W930497132 creator A5083326226 @default.
• W930497132 creator A5090884672 @default.
• W930497132 date "2016-01-01" @default.
• W930497132 modified "2023-10-17" @default.
• W930497132 title "Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes" @default.
• W930497132 cites W1926532831 @default.
• W930497132 cites W1991286554 @default.
• W930497132 cites W1992787503 @default.
• W930497132 cites W1997349061 @default.
• W930497132 cites W2002593213 @default.
• W930497132 cites W2005107590 @default.
• W930497132 cites W2012671124 @default.
• W930497132 cites W2012972996 @default.
• W930497132 cites W2051481652 @default.
• W930497132 cites W2059513413 @default.
• W930497132 cites W2063641258 @default.
• W930497132 cites W2066795537 @default.
• W930497132 cites W2145664048 @default.
• W930497132 cites W2161608686 @default.
• W930497132 cites W4230784343 @default.
• W930497132 doi "https://doi.org/10.1016/j.braindev.2015.06.008" @default.
• W930497132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26183863" @default.
• W930497132 hasPublicationYear "2016" @default.
• W930497132 type Work @default.
• W930497132 sameAs 930497132 @default.
• W930497132 citedByCount "45" @default.
• W930497132 countsByYear W9304971322016 @default.
• W930497132 countsByYear W9304971322017 @default.
• W930497132 countsByYear W9304971322018 @default.
• W930497132 countsByYear W9304971322019 @default.
• W930497132 countsByYear W9304971322020 @default.
• W930497132 countsByYear W9304971322021 @default.
• W930497132 countsByYear W9304971322022 @default.
• W930497132 countsByYear W9304971322023 @default.
• W930497132 crossrefType "journal-article" @default.
• W930497132 hasAuthorship W930497132A5013245506 @default.
• W930497132 hasAuthorship W930497132A5045525134 @default.
• W930497132 hasAuthorship W930497132A5046996814 @default.
• W930497132 hasAuthorship W930497132A5054303004 @default.
• W930497132 hasAuthorship W930497132A5054952702 @default.
• W930497132 hasAuthorship W930497132A5073459365 @default.
• W930497132 hasAuthorship W930497132A5083326226 @default.
• W930497132 hasAuthorship W930497132A5090884672 @default.
• W930497132 hasConcept C118552586 @default.
• W930497132 hasConcept C126322002 @default.
• W930497132 hasConcept C2777138316 @default.
• W930497132 hasConcept C2777332695 @default.
• W930497132 hasConcept C2777683783 @default.
• W930497132 hasConcept C2777907850 @default.
• W930497132 hasConcept C2778186239 @default.
• W930497132 hasConcept C2778802184 @default.
• W930497132 hasConcept C2779253243 @default.
• W930497132 hasConcept C2779426884 @default.
• W930497132 hasConcept C2780623815 @default.
• W930497132 hasConcept C42219234 @default.
• W930497132 hasConcept C71924100 @default.
• W930497132 hasConcept C98274493 @default.
• W930497132 hasConceptScore W930497132C118552586 @default.
• W930497132 hasConceptScore W930497132C126322002 @default.
• W930497132 hasConceptScore W930497132C2777138316 @default.
• W930497132 hasConceptScore W930497132C2777332695 @default.
• W930497132 hasConceptScore W930497132C2777683783 @default.
• W930497132 hasConceptScore W930497132C2777907850 @default.
• W930497132 hasConceptScore W930497132C2778186239 @default.
• W930497132 hasConceptScore W930497132C2778802184 @default.
• W930497132 hasConceptScore W930497132C2779253243 @default.
• W930497132 hasConceptScore W930497132C2779426884 @default.
• W930497132 hasConceptScore W930497132C2780623815 @default.
• W930497132 hasConceptScore W930497132C42219234 @default.
• W930497132 hasConceptScore W930497132C71924100 @default.
• W930497132 hasConceptScore W930497132C98274493 @default.
• W930497132 hasFunder F4320320912 @default.
• W930497132 hasFunder F4320334764 @default.
• W930497132 hasIssue "1" @default.
• W930497132 hasLocation W9304971321 @default.
• W930497132 hasLocation W9304971322 @default.
• W930497132 hasOpenAccess W930497132 @default.
• W930497132 hasPrimaryLocation W9304971321 @default.
• W930497132 hasRelatedWork W1496852942 @default.
• W930497132 hasRelatedWork W1965127622 @default.
• W930497132 hasRelatedWork W2060769952 @default.
• W930497132 hasRelatedWork W2105615052 @default.
• W930497132 hasRelatedWork W2258 @default.
• W930497132 hasRelatedWork W2335316218 @default.
• W930497132 hasRelatedWork W3027454642 @default.
• W930497132 hasRelatedWork W3109587470 @default.
• W930497132 hasRelatedWork W4290433016 @default.
• W930497132 hasRelatedWork W4308446429 @default.
• W930497132 hasVolume "38" @default.
• W930497132 isParatext "false" @default.

• next